HealthArriVent lung cancer treatment fails late-stage trial
ArriVent BioPharma said on Tuesday that its therapy for patients with a type of lung cancer failed to meet the primary goal of a late-stage trial.
R
Reuters★★☆☆☆2026-10-06 13:10Original
ArriVent lung cancer treatment fails late-stage trial
Health